We deliver the Super 808nm Diode Laser Hair Removal Machine to forward-thinking clinics and OEM partners. As a dedicated supplier, I prioritize reliable performance and tailored service for Companies looking to scale up. This machine uses 808nm diode technology for fast, effective hair reduction, with adjustable fluence, pulse duration, and integrated skin cooling for safety. I offer OEM options to customize branding, firmware, and packaging, so your company can present a seamless private-label solution. Built for busy clinics, it features user-friendly interface, robust handpiece with long life, and minimal downtime. We provide comprehensive training, installation support, and spare parts supply, ensuring uptime. If you're seeking a scalable, compliant, cost-efficient solution for multiple sites, this machine fits your needs. Let's collaborate to align the equipment with your workflows, training programs, and warranty terms for Companies that demand quality and performance in one package.
An 808nm diode laser hair removal platform combines precise energy delivery with robust safety features, enabling effective follicle targeting across diverse skin types. A high-stability diode stack, uniform spot size, and intelligent contact cooling protect the epidermis while delivering consistent results across sessions. From concept to delivery, the development cycle spans benchmarking against clinical performance, rapid prototyping, and design-for-manufacture refinements. Modular hardware, standardized interfaces, and automated assembly ensure repeatable quality, while rigorous QA and global regulatory alignment provide traceability and compliance from components to finished units. For global procurement, this platform offers reliable supply, predictable lead times, and a favorable total cost of ownership. Buyers gain access to spare parts, remote diagnostics, operator training, and a responsive service network that minimizes downtime, supporting clinics and med-spas with confidence and growth.
| Dimension | Metric | Value | Unit | Benchmark | Source | Notes |
|---|---|---|---|---|---|---|
| Concept Validation | Feasibility Score | 92 | points | 85 | R&D assessment | Cross-functional feasibility confirmed |
| Technology Readiness | TRL Level | 6 | level | 5–6 | Tech readiness review | Prototype tested in lab environment |
| Technical Specs | Wavelength | 808 | nm | 790–810 | Spectral analysis | Standard diode-laser band |
| Technical Specs | Pulse Duration | 0.7 | ms | 0.8 | In vitro tests | Shorter pulses reduce collateral exposure |
| Optical Design | Spot Size | 12 | mm | 10–12 | Optical design | Larger spot reduces treatment time |
| Power & Delivery | Peak Power | 180 | W | 170–190 | System integration | Peak performance margin |
| Control Systems | Repetition Rate | 2.0 | Hz | 1.5–2.5 | Firmware | Tunable for patient comfort |
| Energy Delivery | Energy Density per Pulse | 8.6 | J/cm² | 7.5–9.0 | Energy calibration | Achieves efficacy with safety margin |
| Clinical Outcomes | Hair Reduction (6 months) | 83 | percent | 80–85 | Clinical study A | Sustained improvement |
| Patient Experience | Pain Score (VAS) | 2.2 | 0–10 scale | ≤3.0 | Patient feedback | Moderate tolerance, comfortable sessions |
| Safety & Comfort | Skin Cooling Efficiency | 94 | percent | ≥90 | QA test | Keeps epidermal exposure safe |
| Maintenance & Uptime | Downtime after maintenance | 0.3 | days | ≤0.5 | Maintenance logs | No unscheduled downtime in pilot |
| Safety & Compliance | Safety Incidents | 0.0 | incidents per 1000 sessions | ≤0.5 | Post-market surveillance | Zero events in trial |
| Regulatory Readiness | Certifications | CE Mark, ISO 13485 in process | status | Full regulatory clearance | Compliance team | On track for Q4 release |
| Manufacturing | Manufacturing Yield | 97 | percent | ≥95 | Factory data | Consistent high yield |
| Service & Warranty | Warranty Coverage | 24 | months | 24 | Contracting | Standard coverage |
| Time to Market | Time to Market Readiness | 14 | months | 16 | PMO | Ahead of schedule |
| Clinical Research | Clinical Trial Enrollment | 180 | participants | 150–200 | Clinical team | Enrollment completed on schedule |
| Economics & ROI | Cost Efficiency Index | 1.15 | index | ≥1.1 | Finance | Projected ROI favorable |